Government must help biotech: Clarke
07 May, 2002 by Tanya HollisThe suspension of the Federal government's R&D Start program, purportedly for being too successful, flew in the face of Australia's need to compete in the global biotechnology arena, Prof Adrienne Clarke has warned.
Study to look at ecosystems' genetic viability
06 May, 2002 by Melissa TrudingerA study is underway in NSW and WA to examine endangered ecosystems using genetic techniques.
Bad data warning over public gene databases
06 May, 2002 by Pete YoungSome of the most-used global databases of DNA and amino acid sequences are riddled with errors and there is no quick fix in sight.
Biotech the engine for IT - but who's driving?
03 May, 2002 by Melissa TrudingerThe biological sciences are now the driving force for the development of advanced computing, according to Compaq Computer Corp executive Lionel Binns. But there's a catch, he warned - there aren't enough computer scientists to go around, and this would increasingly be a problem for the industry.
Gene chip market tipped to soar
03 May, 2002 by Iain ScottUK-based analyst Datamonitor has tipped a massive increase in the global gene chip market over the next four years, from $322 million in 2000 to $1.2 billion by 2006.
Venter sets up non-profits for gene ethics, applications
02 May, 2002 by George A ChidiCelera Genomics Group founder Craig Venter has formed three not-for-profit organisations to study the ethics and social implications of genetic technology, and to look for applications of biotechnology in energy production.
Ambri gets new business software
01 May, 2002 by Daniella GoldbergAmbri has adopted new business software and services from Frontstep, to help it to take its new clinical diagnostic system from prototype to full-scale manufacture.
Confirmant set to release Protein Atlas
29 April, 2002 by Marc FerrantiUS company Confirmant is racing to finish up the first commercial version of its Protein Atlas for June, but life science researchers and industry analysts say a warm reception is far from assured.
Analyst IDC bets on bio-IT boom
23 April, 2002 by Iain ScottSpending on IT products and services by life science companies will reach $US38 billion by 2006, according to market analyst IDC.
Power pool: how grid computing can benefit bio
23 April, 2002 by Staff WritersDistributed processing gets an updated look as vendors go for the grid: In early 2000, Cereon Genomics had a serious situation on its hands: It was running out of computing power.
Aussie scientists, ethicists blast human cloning news
08 April, 2002 by Tanya HollisAustralian scientists and ethicists have expressed dismay and disbelief at reports a woman is eight weeks pregnant with the world's first human clone.
Bioinformatics: Lights on, no one home?
05 April, 2002 by Iain ScottPilots, not planes, are needed to get Australia's nascent bioinformatics industry off the ground, according to one of the authors of a new report.
Patents shouldn't apply to gene sequences: Affymetrix
05 April, 2002 by Melissa TrudingerUS company Affymetrix has told a government panel that patents should not be applied to gene sequences.
Bio gold rush could pay off for enterprise IT
04 April, 2002 by Elizabeth HeichlerLike most of us, IT managers at major retailing or banking companies probably find the current revolution in life sciences research compelling because of its promise to disarm hereditary diseases or cancers. But they may not realise that they also have a professional self-interest in computationally driven work on genetics, proteins, and pharmaceuticals.
Genaissance announces initial STRENGTH findings
02 April, 2002 by Malorye BrancaResearchers at Genaissance Pharmaceuticals have found "statistically significant" associations between genetic markers and certain patient responses to cholesterol-lowering drugs. Such associations, or links, could be used to develop pharmacogenomic tests that would help physicians determine the best drug for a particular patient.
